CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

MedAvante

MedAvante, Inc. is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lifespark

Lifespark is a complete senior health company that helps people stay healthy at home, navigate their health options with confidence, and live fuller, more independent lives.

Dynavax Technologies Corporation

Dynavax Technologies Corporation is a biopharmaceutical company that discovers and develops a pipeline of Toll-like Receptor (TLR) product candidates.

Reviva Laboratories

Reviva Labs creates safe, effective natural skin care treatments that produce visible results. It`s why skin care enthusiasts have fallen in love with our skin care over the last 40+ years and why Reviva has become the natural skin care trusted for generations.

Sav-Rx

Sav-Rx is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.